Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.
Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback